Home > Insider Trading > Filing (0001138723-11-000045)

Filing Details

Accession Number:: 0001138723-11-000045
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-26 20:03:31
Reporting Period:: 2011-08-24

Filing Date:: 2011-08-26
Accepted Time:: 2011-08-26 20:03:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138723	Accuray Inc	ARAY	Surgical & Medical Instruments & Apparatus (3841)	770268932

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1387516	Euan Thomson	1310 Chesapeake Terrace Sunnyvale CA 94089	President & Ceo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-08-24	10,000	$0.75	192,132	No	4	M	Direct
Common Stock	Disposition	2011-08-24	10,000	$4.72	182,132	No	4	S	Direct
Common Stock	Acquisiton	2011-08-25	10,000	$0.75	192,132	No	4	M	Direct
Common Stock	Disposition	2011-08-25	10,000	$4.62	182,132	No	4	S	Direct
Common Stock	Acquisiton	2011-08-25	12,000	$2.50	194,132	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right to buy)	Disposition	2011-08-25	12,000	$0.00	12,000	$2.50
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2011-08-24	10,000	$0.00	10,000	$0.75
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2011-08-25	10,000	$0.00	10,000	$0.75

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
63,899	2014-08-10	No	4	M	Direct
472,501	2013-08-27	No	4	M	Direct
462,501	2013-08-27	No	4	M	Direct

Footnotes

A portion of these options are being sold so that a portion of the proceeds may be used to increase the CEO's ownership of Accuray stock in accordance with the adoption of stock ownership guidelines for management by the Board of Directors of Accuray Incorporated in fiscal year 2011.
A total of 10,000 shares were sold pursuant to a 10b5-1 Plan, at an average sale price of $4.7167 per share. The actual sale price for the shares was:200 shares at $4.63; 600 shares at $4.64; 100 shares at $4.65; 200 shares at $4.67; 100 shares at $4.675; 400 shares at $4.68; 100 shares at $4.6802; 800 shares at $4.69; 100 shares at $4.695; 700 shares at $4.70; 1,000 shares at $4.71; 100 shares at $4.7109; 1,100 shares at $4.72; 100 shares at $4.7275; 1,500 shares at $4.73; 300 shares at $4.7305; 200 shares at $4.735; 835 shares at $4.74; 265 shares at $4.75; 200 shares at $4.76; 200 shares at $4.77; 300 shares at $4.78; 100 shares at $4.7807; 300 shares at $4.79; 200 shares at $4.80.
A total of 10,000 shares were sold pursuant to a 10b5-1 Plan, at an average sale price of $4.6232 per share. The actual sale price for the shares was:200 shares at $4.5305; 500 shares at $4.54; 300 shares at $4.5404; 100 shares at $4.5405; 100 shares at $4.5407; 100 shares at $4.5408; 500 shares at $4.55; 800 shares at $4.56; 100 shares at $4.5607; 300 shares at $4.57; 100 shares at $4.5703; 200 shares at $4.58; 100 shares at $4.59; 100 shares at $4.5904; 100 shares at $4.5906; 100 shares at $4.5907; 300 shares at $4.60; 100 shares at $4.6002; 100 shares at $4.6003; 100 shares at $4.6004; 100 shares at $4.6006; 600 shares at $4.61; 500 shares at $4.62; 100 shares at $4.6202; 200 shares at $4.63; 200 shares at $4.64; 100 shares at $4.6405; 300 shares at $4.65; 200 shares at $4.6511; 200 shares at $4.66; 100 shares at $4.6602; 400 shares at $4.67; 100 shares at $4.6703; 800 shares at $4.68; 100 shares at $4.6811; 200 shares at $4.69; 100 shares at $4.70; 100 shares at $4.7007; 400 shares
These options are exercisable as they vest. The shares subject to this stock option become vested and fully exercisable in equal monthly installments, ratably over a period of 48-months.
The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.